Leptin responsiveness restored by amylin agonism in diet-induced obesity: Evidence from nonclinical and clinical studies
Jonathan D. Roth(Rutgers, The State University of New Jersey), Alain Baron(Amplyx Pharmaceuticals (United States)), David G. Parkes(Amplyx Pharmaceuticals (United States)), Christen M. Anderson, Christian Weyer(National Institutes of Health), Barbara Roland, James L. Trevaskis, Rebecca L. Cole, Joy E. Koda
Cited by 433
Related Papers
Hypoadiponectinemia in Obesity and Type 2 Diabetes: Close Association with Insulin Resistance and Hyperinsulinemia
|The Journal of Clinical Endocrinology & Metabolism|2001|3.4k
Circulating Ghrelin Levels Are Decreased in Human Obesity
|Diabetes|2001|2k
Cloning and Functional Expression of the Human Histamine H<sub>3</sub>Receptor
|Molecular Pharmacology|1999|700
Circulating Interleukin‐6 in Relation to Adiposity, Insulin Action, and Insulin Secretion
|Obesity Research|2001|635